Does BROLUCIZUMAB-DBLL Cause Retinal haemorrhage? 111 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 111 reports of Retinal haemorrhage have been filed in association with BROLUCIZUMAB-DBLL. This represents 4.0% of all adverse event reports for BROLUCIZUMAB-DBLL.
111
Reports of Retinal haemorrhage with BROLUCIZUMAB-DBLL
4.0%
of all BROLUCIZUMAB-DBLL reports
1
Deaths
14
Hospitalizations
How Dangerous Is Retinal haemorrhage From BROLUCIZUMAB-DBLL?
Of the 111 reports, 1 (0.9%) resulted in death, 14 (12.6%) required hospitalization.
Is Retinal haemorrhage Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for BROLUCIZUMAB-DBLL. However, 111 reports have been filed with the FAERS database.
What Other Side Effects Does BROLUCIZUMAB-DBLL Cause?
Vitreous floaters (479)
Visual impairment (446)
Vision blurred (416)
Eye inflammation (387)
Visual acuity reduced (365)
Retinal vasculitis (323)
Uveitis (305)
Vitritis (284)
Eye pain (234)
Vitreous opacities (205)
What Other Drugs Cause Retinal haemorrhage?
AFLIBERCEPT (465)
RANIBIZUMAB (437)
BEVACIZUMAB (217)
ASPIRIN (162)
RIVAROXABAN (142)
CYCLOPHOSPHAMIDE (113)
ETOPOSIDE (91)
ADALIMUMAB (90)
PREDNISONE (89)
PREDNISOLONE (88)
Which BROLUCIZUMAB-DBLL Alternatives Have Lower Retinal haemorrhage Risk?
BROLUCIZUMAB-DBLL vs BROMAZEPAM
BROLUCIZUMAB-DBLL vs BROMFENAC
BROLUCIZUMAB-DBLL vs BROMHEXINE
BROLUCIZUMAB-DBLL vs BROMOCRIPTINE
BROLUCIZUMAB-DBLL vs BROTIZOLAM